General Recommendations on Immunization
Source: MMWR, January 28, 2011; 60(RR02):1-60
www.cdc.gov/mmwr/preview/mmwrhtml/rr6002a1.htm
www.cdc.gov/mmwr/pdf/rr/rr6002.pdf
Prevention of Pneumococcal Disease Among Infants
and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent
Pneumococcal Polysaccharide Vaccine
Source: MMWR, December 10, 2010;
59(RR11):1-18
www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm?s_cid=rr5911a1_w
www.cdc.gov/mmwr/PDF/rr/rr5911.pdf
Licensure of a 13-Valent Pneumococcal Conjugate
Vaccine (PCV13) and Recommendations for Use Among Children --- Advisory
Committee on Immunization Practices (ACIP), 2010
Source: MMWR, March 12, 2010; 59(09):258-261
www.cdc.gov/mmwr/preview/mmwrhtml/mm5909a2.htm
www.cdc.gov/mmwr/PDF/wk/mm5909.pdf
Updated Recommendation from the Advisory
Committee on Immunization Practices (ACIP) for Use of 7-Valent Pneumococcal
Conjugate Vaccine (PCV7) in Children Aged 24--59 Months Who Are Not Completely
Vaccinated
Source: MMWR, April 4, 2008; 57(13):343-344
www.cdc.gov/mmwr/preview/mmwrhtml/mm5713a4.htm
www.cdc.gov/mmwr/PDF/wk/mm5713.pdf
Preventing Pneumococcal Disease Among Infants and Young Children. Recommendations of
the Advisory Committee on Immunization Practices (ACIP)
Source: MMWR, October 6, 2000, Vol. 49(RR-9):1-35
www.cdc.gov/mmwr/preview/mmwrhtml/rr4909a1.htm
|
